BTIG's Key Stock Recommendations for Early 2025

BTIG’s Stock Picks for the Start of 2025

As investors gear up for 2025, expectations are moderating regarding growth in the benchmark indices, particularly the S&P 500. Analysts at BTIG, led by Jonathan Krinsky, predict a shift after several years of unprecedented growth in the stock market.

Market Performance Overview

Despite a somewhat sluggish end to the previous year, major U.S. stock indices, including the S&P 500, achieved significant annual increases. In fact, this index experienced its strongest two-year performance since the late 1990s. Much of this optimism has been fueled by the Federal Reserve's recent decision to lower interest rates, transitioning from the high levels maintained over the past few years.

The central bank has pointed to a decline in inflationary pressures stemming from peaks previously seen in recent times. However, some experts caution that this easing trend may have plateaued. During a recent conference, Fed Chair Jerome Powell expressed that the current monetary policy is in a favorable state, hinting at a more cautious approach moving forward.

Political Landscape and Economic Outlook

The political scenario is evolving, too. The incoming administration and a series of victories for Republican candidates during crucial elections may lead to reduced regulations and tax benefits for businesses. Nonetheless, there remains uncertainty surrounding economic policies, including tariffs and immigration reforms, and their potential impact on inflation rates.

A remarkable interest in artificial intelligence technologies has led to substantial gains for companies involved in this sector. Notably, Nvidia has emerged as the leader in market capitalization growth, primarily due to the skyrocketing demand for AI-based chips. This tech giant added over $2 trillion to its market value in the past year, positioning itself as a frontrunner among global corporations.

Market Breadth and Investor Sentiment

BTIG’s Krinsky highlights that while early gains in the stock markets were mainly driven by a few mega-cap companies like Nvidia, expectations were that broader participation would follow with rate cuts. By the end of the past year, however, less than 60% of stocks in the S&P 500 were above their 200-day moving average, marking a concerning trend. Krinsky suggests this situation may either loom as a cautionary signal or present a buying opportunity for astute investors.

Key Stock Selections by BTIG

With the market dynamics evolving, BTIG has identified several stock picks for the first half of 2025 that could hold significant promise:

Bloom Energy Corp (NYSE: BE)

After almost four years of continuous decline, Bloom Energy's stock broke out of its pattern with a significant upward movement in November, presenting potential for considerable gains.

Expedia Inc (NASDAQ: EXPE)

Following a substantial base formation from 2022 to 2024, Expedia's stock showed a breakout in November. A breakthrough above $192 could see it test previous all-time highs from early 2022.

Globus Medical (NYSE: GMED)

Globus Medical has recently reversed a prolonged downtrend, surpassing the 2021 peak. Although some consolidation may follow, the stock has solid support around the $75-$80 range.

Health Equity (NASDAQ: HQY)

After a period of consolidation earlier in the year, Health Equity saw its stock push higher after breaking out in November, indicating strong upward momentum.

On Holdings (NYSE: ONON)

On Holdings has displayed a robust upward trend, with the stock primed for further gains above $60 as it continues to consolidate.

Regency Centers (NASDAQ: REG)

Regency Centers has navigated a sideways trading range until recently. Now, it appears poised to break out following its range-bound activity in the last several months.

Block Inc (NYSE: SQ)

Block Inc has emerged from a long period of trading sideways and broke through its resistance. After approaching the $100 mark, the stock looks set to continue its upward trajectory.

Verona Pharma PLC (NASDAQ: VRNA)

With a robust trend established over the past six months, Verona Pharma has surged in value significantly. As long as this trend holds, it remains a favorable investment option.

Frequently Asked Questions

What are BTIG's top stock picks for 2025?

BTIG's notable stock picks include Bloom Energy Corp, Expedia Inc, Globus Medical, Health Equity, On Holdings, Regency Centers, Block Inc, and Verona Pharma PLC.

Why is the S&P 500 growth expected to slow down in 2025?

Analysts predict moderation due to earlier high growth rates, changes in Federal Reserve policies, and the overall economic landscape.

How has AI impacted the stock market?

Rapid advancements in artificial intelligence have significantly boosted stock valuations for companies like Nvidia, which saw massive demand for its AI technologies.

What does market breadth indicate?

Market breadth reflects the percentage of stocks trading above their 200-day moving average and can signal market strength or potential downturns based on investor sentiment.

What factors could influence stock performance in 2025?

Factors include government policy changes, inflation rates, interest rate adjustments by the Federal Reserve, and innovations in technology sectors.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.